Indaptus Therapeutics Shares Rise After Entering $24 Million Private Placement

03:20 PM EDT, 09/10/2026 (MT Newswires) -- Indaptus Therapeutics (INDP) shares rose nearly 22% in Thursday afternoon trading after the company entered into a stock purchase agreement to raise around $24 million. The clinical-stage biotechnology company has agreed to issue and sell roughly 20.3 million shares in a private placement. It plans to use the net proceeds for working capital and research and development, including early-stage research and preclinical evaluation of a potential neurotechnology and neural network-based device for certain sleep-related conditions, the company added. Price: 2.51, Change: +0.43, Percent Change: +20.67